SpacePharma SA selected ISIS – Innovative Solutions In Space B.V. to build the platform and integrate the payload for their next mission, DIDO-3, with support for satellite commissioning after launch. The agreement is a continuation of a fruitful cooperation to realize SpacePharma’s previous satellite, named DIDO-2, which was the proof of concept mission to test miniaturized end-to-end pharmaceutical laboratory in space, allowing microgravity conditions.
[Follow this link for full article](https://www.isispace.nl/news/isis-selected-by-spacepharma-again-to-realize-their-next-dido-mission/)
